Familial polymorphic ventricular tachycardia--intracellular calcium channel disorder

International Multicenter Cohort Study on Beta-Blocker-Free Treatment Strategies for Catecholaminergic Polymorphic Ventricular Tachycardia Patients.

JACC. Clinical electrophysiology·2024

An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia.

Heart rhythm·2024

Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.

Circulation·2023

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity.

BMC cardiovascular disorders·2023

Effects of β-blockers on ventricular repolarization documented by 24-hour electrocardiography in long QT syndrome type 2.

Heart rhythm·2022

An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.

Circulation·2021

Cost-effectiveness of the implantable cardioverter defibrillator.

Cardiac electrophysiology review·2004

Clinical significance of device-related complications in clinical trials and implications for future trials: insights from the Antiarrhytmics Versus Implantable Defibrillators (AVID) trial.

Cardiac electrophysiology review·2004

The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.

Cardiac electrophysiology review·2004

Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?

Cardiac electrophysiology review·2004

DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).

Cardiac electrophysiology review·2004

Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.

Cardiac electrophysiology review·2004

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

Journal of the American College of Cardiology·2026

Effect of colchicine on C-reactive protein level following hospitalization for myocardial infarction: a meta-analysis of randomized, placebo-controlled trials.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026

Related Experiment Videos

Familial polymorphic ventricular tachycardia--intracellular calcium channel disorder

Related Concept Videos

International Multicenter Cohort Study on Beta-Blocker-Free Treatment Strategies for Catecholaminergic Polymorphic Ventricular Tachycardia Patients.

An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia.

Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity.

Effects of β-blockers on ventricular repolarization documented by 24-hour electrocardiography in long QT syndrome type 2.

An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.

Cost-effectiveness of the implantable cardioverter defibrillator.

Clinical significance of device-related complications in clinical trials and implications for future trials: insights from the Antiarrhytmics Versus Implantable Defibrillators (AVID) trial.

The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.

Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?

DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).

Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

Effect of colchicine on C-reactive protein level following hospitalization for myocardial infarction: a meta-analysis of randomized, placebo-controlled trials.

Related Experiment Videos

Familial polymorphic ventricular tachycardia--intracellular calcium channel disorder

Related Concept Videos

Related Articles